id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-M-2460-0002,FDA,FDA-2018-M-2460,"Medical Devices; Availability of Safety and Effectiveness Summaries for
Premarket Approval Applications",Notice,Notice of Publication,2018-11-16T05:00:00Z,2018,11,2018-11-16T05:00:00Z,,2018-11-16T16:31:59Z,2018-25071,0,0,09000064838e0939
FDA-2018-M-2460-0001,FDA,FDA-2018-M-2460,Premarket Approval Response from FDA CDRH to Glaukos Corporation,Other,Approval,2018-08-01T04:00:00Z,2018,8,2018-08-01T04:00:00Z,,2018-08-01T14:01:34Z,,0,0,09000064835aea1c